Funder: Alnylam Pharmaceuticals
Due Dates: Rolling (submit ≥45 days before activity start date)
Funding Amounts: No fixed minimum or maximum; awards may be less than requested; duration/activity-based.
Summary: Supports independent, evidence-based educational initiatives for healthcare professionals, patients, and the healthcare community in rare disease areas (ATTR amyloidosis, AHP, PH1).
Key Information: Applications must be submitted via portal at least 45 days before activity; only organizations (not individuals) are eligible.